Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.

Zdenek RácilEva KoritakovaTomasz SachaHana KlamovaPetra BelohlavkovaEdgar FaberDelphine ReaLudmila MalaskovaJirina ProchazkovaDaniela ZackovaJaroslava VoglovaJoanna WącławPetr CetkovskyPavel ZakJiri Mayer

Published in: American journal of hematology (2018)

Keyphrases

insulin resistance
adipose tissue
metabolic syndrome
type diabetes
high fat diet
polycystic ovary syndrome
chronic myeloid leukemia
skeletal muscle
high fat diet induced
mesenchymal stem cells
glycemic control
bone marrow
weight loss